Form 4: McCormick & Co. Director Kurzius Exercises Options and Sells Shares
SEC Form 4 Filing
Director Lawrence Erik Kurzius reports exercising stock options and selling shares of McCormick & Co. on May 21, 2024.
Summary
- Lawrence Erik Kurzius, a director at McCormick & Co., executed transactions involving the company's stock.
- On May 21, 2024, Kurzius exercised options to acquire 80,000 shares of common stock at a price of $38.145 per share.
- Simultaneously, Kurzius sold 80,000 shares of common stock at a price of $73.7503 per share.
- Following these transactions, Kurzius directly owns 199,258 shares of McCormick & Co. common stock.
- Kurzius also indirectly owns shares through an IRA (25,000 shares), a 401(k) Retirement Plan (14,455.4952 shares), and several GRATs (ranging from 5,904 to 13,604 shares each).
- Additionally, Kurzius indirectly holds 31,081.51 shares through a Non Qualified Retirement Plan.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather reports factual information.
Industry Context
This filing is a routine disclosure of insider transactions, which are common among corporate executives and directors. These transactions are legal as long as they comply with SEC regulations and insider trading laws.
Comparison to Industry Standards
- Insider trading activity is a common occurrence in publicly traded companies.
- Comparing Kurzius's transactions to those of other directors in similar-sized companies within the consumer staples sector would provide a benchmark.
- Companies like Nestle, Unilever, and Kraft Heinz also have directors who regularly report stock transactions.
Stakeholder Impact
- The transactions could have a minor impact on shareholders due to the change in ownership, but the effect is likely minimal given the overall size of the company.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 03/25/2016 | Date options were granted that were exercised on 05/21/2024 |
| 04/22/2024 | Transaction date for dividend reinvestment of phantom stock. |
| 05/21/2024 | Date of option exercise and share sale. |
| 05/22/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.